Security key
046513107
Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (ATRA)
CUSIP: 046513107
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 99,815,040
- Total 13F value
- $777,439,383
- Share change
- +1,968,494
- SEC-reported price per share
- $7.79
- Number of holders
- 132
- Value change
- +$14,024,584
- Number of buys
- 64
- Number of sells
- 63
- Shares outstanding
- 9,606,000
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
132
Top holders
10
ATRA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Atara Biotherapeutics, Inc. SEC filings
Atara Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 046513107
Recent filing periods:
Ownership snapshot
Top reported holders of ATRA - Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
JPMORGAN CHASE & CO
Disclosed value leader
JPMORGAN CHASE & CO
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F
Lead comparable stake: 85%
Showing 1-6 of 15 holder rows.
Quick read
JPMORGAN CHASE & CO leads the comparable SEC ownership view at 85%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens JPMORGAN CHASE & CO's linked filing trail.
Comparable ownership
Top 5
JPMORGAN CHASE & CO
85%
BAUPOST GROUP LLC/MA
85%
MAVERICK CAPITAL LTD
82%
BlackRock Finance, Inc.
81%
VANGUARD GROUP INC
72%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JPMORGAN CHASE & CO |
13F
Company
|
85%
|
$76,085,000
8,189,899 shares
|
— | 31 Mar 2022 |
| BAUPOST GROUP LLC/MA |
13F
Company
|
85%
|
$75,468,000
8,123,616 shares
|
— | 31 Mar 2022 |
| MAVERICK CAPITAL LTD |
13F
Company
|
82%
|
$72,981,000
7,855,824 shares
|
— | 31 Mar 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
81%
|
$72,461,000
7,800,139 shares
|
— | 31 Mar 2022 |
| VANGUARD GROUP INC |
13F
Company
|
72%
|
$64,217,000
6,912,574 shares
|
— | 31 Mar 2022 |
| STATE STREET CORP |
13F
Company
|
65%
|
$58,282,000
6,273,617 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
132
Shares
99,815,040
Rows available
132
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
139
Q2 2022 holders
132
Holder diff
-7
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend